Lynn E. S̄pitler - Concepedia

Author

Lynn E. S̄pitler

Also Known As

L E Spitler, L Spitler, L. E. Spitler, L. Spitler, L.E. SPITLER, L.E. Spitler, LYNN E. SPITLER, Lynn E Spitler, Lynn E. Spitler, Lynn E. S̄pitler

145

Publications

Citations

H-Index

132

Concepts

All Affiliations

University of California, San Francisco Northern California Melanoma Center Huntsman Cancer Institute Mary Crowley Cancer Research Center University of California San Francisco Medical Center

About

Lynn E. S̄pitler is an author at University of California, San Francisco specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	57	3.1K
2	Allergy	18	21	1.8K
3	Health Sciences	9	9	559
4	Allergy Medicine	2	2	129
5	Social Sciences	1	1	43

Lynn E. S̄pitler

Publications

6.7K

Citations

H-Index

Page 1

	Year	Citations
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma Robert H.I. Andtbacka, Howard L. Kaufman, Frances A. Collichio, Journal of Clinical Oncology	2015	2.5K
Plasmapheresis and Immunosuppressive Drug Therapy in Myasthenia Gravis Peter C. Dau, Jon Lindstrom, Christine K. Cassel, New England Journal of Medicine Adrenal GlandAutoimmune DiseaseAllergyCholinesterase InhibitorsLowered Titers	1977	404
Adjuvant Therapy of Stage III and IV Malignant Melanoma Using Granulocyte-Macrophage Colony-Stimulating Factor Lynn E. S̄pitler, Michael L. Grossbard, Marc S. Ernstoff, Journal of Clinical Oncology	2000	266
Rosette-Forming Cells, Immunologic Deficiency Diseases and Transfer Factor Joseph Wybran, Alan S. Levin, Lynn E. S̄pitler, New England Journal of Medicine ImmunohematologyImmunodeficienciesImmunologyPeripheral BloodDermatology	1973	224
Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin. Lynn E. S̄pitler, Maguy Del Rio, Archie Khentigan, PubMed Tumor ImmunologyAllergyAutoimmune DiseaseMetastatic Malignant MelanomaMild Allergic Reactions	1987	215
The Wiskott-Aldrich Syndrome Lynn E. S̄pitler, Alan S. Levin, Daniel P. Stites, Journal of Clinical Investigation ImmunologyPathologyDermatologyImmunotherapyHuman Pathology	1972	178
Wiskott-Aldrich Syndrome, A Genetically Determined Cellular Immunologic Deficiency: Clinical and Laboratory Responses to Therapy with Transfer Factor Alan S. Levin, Lynn E. S̄pitler, D P Stites, Proceedings of the National Academy of Sciences Clinical ImmunologyImmunohematologySkin Test SensitivityEarly AgeLaboratory Immunology	1970	167
Generation of PSA-reactive effector cells after vaccination with a PSA-based vaccine in patients with prostate cancer Norbert Meidenbauer, David T. Harris, Lynn E. S̄pitler, The Prostate	2000	123
OPTiM: A randomized phase III trial of talimogene laherparepvec (T-VEC) versus subcutaneous (SC) granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment (tx) of unresected stage IIIB/C and IV melanoma. Robert Hans Ingemar Andtbacka, Frances A. Collichio, Thomas Amatruda, Journal of Clinical Oncology Cancer ManagementImmunologyPathologyDermatologyImmunotherapy	2013	117
Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor-specific transfer factor. Alan S. Levin, Vera S. Byers, H. Hugh Fudenberg, Journal of Clinical Investigation Surgical OncologyImmunologyImmunoeditingPathologyMetronomic Chemotherapy	1975	100

Page 1